User profiles for KENAN MIDILLI
 | Kenan Midilliİstanbul Üniversitesi-Cerrahpaşa, errahpaşa Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı Verified email at istanbul.edu.tr Cited by 2348 |
Carbapenem-Hydrolyzing Oxacillinase, OXA-48, Persists in Klebsiella pneumoniae in Istanbul, Turkey
Z Aktaş, ÇB Kayacan, I Schneider, B Can, K Midilli… - Chemotherapy, 2008 - karger.com
Background: Two OXA-48-producing Klebsiella pneumoniae isolates(KP-4936 and KP-154488)
were analyzed. Method: Minimum inhibitory concentrations were determined using agar …
were analyzed. Method: Minimum inhibitory concentrations were determined using agar …
[HTML][HTML] Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
Background Blood stream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae
(CRE) are associated with high hospital mortality rates and present a tremendous …
(CRE) are associated with high hospital mortality rates and present a tremendous …
[HTML][HTML] The first clinical case due to AP92 like strain of Crimean-Congo hemorrhagic fever virus and a field survey
Background Crimean-Congo Hemorrhagic Fever (CCHF) is a fatal infection, but no clinical
case due to AP92 strain was reported. We described the first clinical case due to AP92 like …
case due to AP92 strain was reported. We described the first clinical case due to AP92 like …
Rickettsia Species in Ticks Removed from Humans in Istanbul, Turkey
A total of 167 ticks collected from humans in Istanbul (Turkey) in 2006 were screened for
Rickettsia species, and nested PCRs targeting gltA and ompA rickettsial fragment genes were …
Rickettsia species, and nested PCRs targeting gltA and ompA rickettsial fragment genes were …
[HTML][HTML] Crimean-Congo hemorrhagic fever among health care workers, Turkey
We investigated 9 cases of Crimean-Congo hemorrhagic fever (1 fatal, 2 asymptomatic)
among health care workers in Turkey. Needlestick injuries were reported for 4 workers. Eight …
among health care workers in Turkey. Needlestick injuries were reported for 4 workers. Eight …
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection
Background and Objectives Healthcare workers (HCWs) were among the first groups to be
vaccinated in Turkey. The data to be obtained by the vaccination of HCWs would guide wide …
vaccinated in Turkey. The data to be obtained by the vaccination of HCWs would guide wide …
[HTML][HTML] Infective endocarditis in Turkey: aetiology, clinical features, and analysis of risk factors for mortality in 325 cases
Objective In order to define the current characteristics of infective endocarditis (IE) in Turkey,
we evaluated IE cases over a 14-year period in a tertiary referral hospital. Methods All adult …
we evaluated IE cases over a 14-year period in a tertiary referral hospital. Methods All adult …
[HTML][HTML] Imported Crimean-Congo hemorrhagic fever cases in Istanbul
We described a series of imported cases of Crimean-Congo Hemorrhagic Fever (CCHF) in
Istanbul and investigated the genetic diversity of the virus. All the suspected cases of CCHF, …
Istanbul and investigated the genetic diversity of the virus. All the suspected cases of CCHF, …
Crimean-Congo hemorrhagic fever in European part of Turkey: genetic analysis of the virus strains from ticks and a seroepidemiological study in humans
A survey of ticks from domestic ruminants, together with a serosurvey in humans was
conducted in Thrace (northwestern Turkey) to evaluate the prevalence of Crimean-Congo …
conducted in Thrace (northwestern Turkey) to evaluate the prevalence of Crimean-Congo …
Effect of BTN162b2 and CoronaVac boosters on humoral and cellular immunity of individuals previously fully vaccinated with CoronaVac against SARS‐CoV‐2: a …
Background It is essential to know about immune response levels after booster doses of the
two different types of vaccines, mRNA, and the inactivated, currently used against COVID‐19…
two different types of vaccines, mRNA, and the inactivated, currently used against COVID‐19…